All News
Filter News
Found 806,076 articles
-
NKMax America Doses First Subject in Phase I Trial of SNK in Patients with Refractory Cancer
8/13/2019
NKMax America, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell therapies, today announced that it has dosed the first subject in study SNK01-US01, a phase I clinical trial evaluating SNK, an ex vivo expanded autologous natural killer cell therapeutic, in patients with pathologically confirmed cancer refractory to conventional therapy.
-
Medica Introduces Insulin Cost Relief Program in North Dakota
8/13/2019
Medica today announced it will expand to North Dakota its cap on the maximum amount members in the state will pay for their insulin.
-
InMode Reports Second Quarter 2019 Financial Results; Record Quarterly Revenue of $38.8 Million Reflects Growth of 55% Over Prior Year
8/13/2019
InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced financial results for the second quarter ended June 30, 2019.
-
GateHouse Treatment and GH Recovery Solutions Announce Appointment of Chad Clardy as Senior Vice President of Clinical Outreach
8/13/2019
GateHouse Treatment and GH Recovery Solutions, New England's premier providers of drug and alcohol treatment programs, today announced that Chad Clardy has joined the organization as Senior Vice President of Clinical Outreach
-
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2020 Release Date
8/13/2019
Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that the Company plans to release its first quarter fiscal year 2020 financial results on Tuesday, August 27, 2019 after the close of trading.
-
Zyla Life Sciences Reports Second Quarter 2019 Financial Results
8/13/2019
Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial-stage life sciences company, today reported financial results for the second quarter ended June 30, 2019 including net sales from commercial products
-
Giant Food Announces the Launch of the 15th Annual Pediatric Cancer Fundraising Program With $2 Million Goal
8/13/2019
Giant Food, the leading greater Washington D.C. regional grocery chain, announced today the launch of the 15th annual fundraising program for pediatric cancer designed to support cancer research initiatives.
-
Newport Academy Announces Opening of Pacific Northwest Mental Health Treatment Program Led by Executive Director Edward Mosshart, LMHC
8/13/2019
Newport Academy, a series of leading adolescent and young adult treatment centers specializing in mental health, trauma, eating disorders, and substance use disorder, recently announced the acquisition of a Washington-based teen and young adult treatment program that is now officially open under the leadership of seasoned behavioral healthcare professional Edward Mosshart, LMHC
-
Leveraging technology for health care system transformation: The time is now
8/13/2019
For two days, over 1,000 physicians, health stakeholders and patients came together in Toronto to explore how leveraging technology will improve the health care system.
-
GetInsured Eliminates Nevada Medical Debt Totaling More Than Half A Million Dollars After New Survey Reveals Concerns Over High Cost of Health Care
8/13/2019
GetInsured, a leading provider of health insurance marketplace technology, retired $580,899 of medical debt in the state of Nevada after its first-ever Nevada Resident Medical Debt Survey revealed more than half (55 percent) of respondents did not seek and/or declined medical treatment out of fear of what it might cost.
-
AJMC® Study Determines Societal Impact of CAR T-Cell Treatment Delays
8/13/2019
Potentially curative cancer treatments, like chimeric antigen receptor (CAR) T-cell therapies, have revolutionized care for illnesses once thought to be a death sentence after relapse, such as pediatric acute lymphoblastic leukemia (pALL) and diffuse large B-cell lymphoma (DLBCL).
-
Grenco Science and Vapium Announce Joint Venture to Introduce Accudose, a First-of-Its-Kind, Accurate Dosing Technology for Cannabis Consumption
8/13/2019
Grenco Science, the leader in advanced technology cannabis vaporization, announces a joint venture with Vapium, the award-winning vaporization company and resident of Johnson & Johnson Innovation - JLABS (JLABS), and investee of Canopy Growth
-
MediRevv and Providence St. Joseph Health Expand Partnership with Second End-to-End Revenue Cycle Model
8/13/2019
MediRevv, a leading national revenue cycle management company, and Providence St. Joseph Health, a national not-for-profit Catholic health system, are pleased to announce a new end-to-end revenue cycle model for billing and coding at Facey Medical Group.
-
Azura Vascular Care brand expands into Montgomery, Alabama
8/13/2019
Azura Vascular Care announced recently that, as part of a phased brand rollout, Capitol City Vascular Care will now be known as Azura Vascular Care Capitol City.
-
Clinical Architecture Unveils Pivot: Managed Interoperability and Data Quality in a Turnkey Solution
8/13/2019
Clinical Architecture is excited to announce the release of Pivot, a turnkey interoperability and data quality solution designed to dramatically reduce the barriers and effort necessary in making high-quality patient information exchange a reality.
-
New Nephron Partnership Offers Solution for Opioid Crisis
8/13/2019
Nephron Pharmaceuticals Corporation today announced a new partnership with InfuTronix Solutions, LLC.
-
Impact Cryotherapy Continues to Lead Whole Body Cryotherapy Industry Safety Standards
8/13/2019
Impact Cryotherapy, Inc., the leading manufacturer of whole body cryosaunas in the US, continues to set the standard for safety in the cryotherapy industry and recently concluded a Human Factors Evaluation, “HFE”, of its cryosauna, operator’s manual, training documents and training videos
-
AtriCure Completes Acquisition of SentreHEART
8/13/2019
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has completed its previously announced acquisition of SentreHEART, Inc., a privately held developer of percutaneous left atrial appendage management solutions.
-
Georgia-based Hamilton Health Care System First in U.S. to Use New Baxter Technology in the ICU
8/13/2019
Baxter’s innovative PrisMax system for managing acute kidney injury (AKI) is now FDA cleared and available in the U.S.
-
ZOLL Foundation Announces Grant Application Submission Deadline of September 30, 2019
8/13/2019
Record Applicants and Grants Awarded in First 2019 Round